WARD

DEVICE3 trials

Sponsors

Murdoch Childrens Research Institute, Rigshospitalet, Denmark

Conditions

CRS - Cytokine Release SyndromeCellulitisHematologic CancerVital Signs

Unknown Phase

Comparing the Intravenous Treatment of Skin Infections in Children, Home Versus Hospital

CompletedNCT02334124

Murdoch Childrens Research InstituteCellulitis

Start: 2015-01-31End: 2022-11-30Updated: 2022-11-08

Using Technical Filtering and Clinical Criteria to Reduce Vital Sign Alarms Using Continuous Monitoring in the Ward

CompletedNCT05171322

Rigshospitalet, DenmarkVital Signs

Start: 2018-02-20End: 2021-01-15Updated: 2022-01-14

Early Detection of Complications During Immunotherapy for Haematological Malignancy

RecruitingNCT06377059

Rigshospitalet, DenmarkCRS - Cytokine Release Syndrome, Hematologic Cancer

Start: 2024-12-02End: 2027-07-01Target: 100Updated: 2026-03-13

Related Papers

Intravenous ceftriaxone at home versus intravenous flucloxacillin in hospital for children with cellulitis: a cost-effectiveness analysis.

2019-08-1323 citations

Efficacy and safety of intravenous ceftriaxone at home versus intravenous flucloxacillin in hospital for children with cellulitis (CHOICE): a single-centre, open-label, randomised, controlled, non-inferiority trial.

2019-03-0720 citations

285. Challenging the Dogmas of Outpatient Parenteral Antimicrobial Therapy Through a Randomized Controlled Trial

Open Forum Infectious Diseases2018-11-01

Cellulitis: Home Or Inpatient in Children from the Emergency Department (CHOICE): protocol for a randomised controlled trial.

2016-01-114 citations